Myocd regulates airway smooth muscle cell remodeling in response to chronic asthmatic injury
The Journal of Pathology · 2023
DOI: 10.1002/path.6044 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Qin Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Airway Remodeling, Asthma, Nuclear Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Abnormal growth of airway smooth muscle cells is one of the key features in asthmatic airway remodeling, which is associated with asthma severity. The mechanisms underlying inappropriate airway smooth muscle cell growth in asthma remain largely unknown. Myocd has been reported to act as a key transcriptional coactivator in promoting airway‐specific smooth muscle development in fetal lungs. Whether Myocd controls airway smooth muscle remodeling in asthma has not been investigated. Mice with lung mesenchyme‐specific deletion of Myocd after lung development were generated, and a chronic asthma model was established by sensitizing and challenging the mice with ovalbumin for a prolonged period. Comparison of the asthmatic pathology between the Myocd knockout mice and the wild‐type controls revealed that abrogation of Myocd mitigated airway smooth muscle cell hypertrophy and hyperplasia, accompanied by reduced peri‐airway inflammation, decreased fibrillar collagen deposition on airway walls, and attenuation of abnormal mucin production in airway epithelial cells. Our study indicates that Myocd is a key transcriptional coactivator involved in asthma airway remodeling. Inhibition of Myocd in asthmatic airways may be an effective approach to breaking the vicious cycle of asthmatic progression, providing a novel strategy in treating severe and persistent asthma. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- Department of Respiratory Medicine, Shenzhen Children's Hospital, Shenzhen, PR China.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Wei Shi
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Yang, Q., Miao, Q., Chen, H., Li, D., Luo, Y., Chiu, J., Wang, H. J., Chuvanjyan, M., Parmacek, M. S., & Shi, W. (2023). Myocd regulates airway smooth muscle cell remodeling in response to chronic asthmatic injury. The Journal of Pathology. https://doi.org/10.1002/path.6044
Vancouver
Yang Q, Miao Q, Chen H, Li D, Luo Y, Chiu J, et al. Myocd regulates airway smooth muscle cell remodeling in response to chronic asthmatic injury. The Journal of Pathology. 2023. doi:10.1002/path.6044
BibTeX
@article{Yang2023,
author = {Yang, Qin and Miao, Qing and Chen, Hui and Li, Duo and Luo, Yongfeng and Chiu, Joanne and Wang, Hong-Jun and Chuvanjyan, Michael and Parmacek, Michael S and Shi, Wei},
title = {Myocd regulates airway smooth muscle cell remodeling in response to chronic asthmatic injury},
journal = {The Journal of Pathology},
year = {2023},
doi = {10.1002/path.6044}
}
EUVIMED